Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Insolvency and Bankruptcy Insolvency and Bankruptcy + HC Insolvency and Bankruptcy - 2022 (4) TMI HC This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2022 (4) TMI 1212 - HC - Insolvency and Bankruptcy


Issues:
1. Whether the mere filing of a proceeding under Section 7 of the Insolvency and Bankruptcy Code, 2016 (IBC) creates an embargo on the Court considering an application under Section 11 of the Arbitration and Conciliation Act, 1996 (ACA) to appoint an arbitral tribunal.
2. The maintainability of the Section 11 application in light of prior proceedings filed under Section 7 of the IBC.
3. The impact of the Supreme Court decision in "Indus Biotech Private Limited vs. Kotak India Venture (Offshore) Fund" on the present case.
4. Whether the applicant should have filed an application under Section 8 of the ACA before the NCLT.

Detailed Analysis:

Issue 1: Embargo on Court Considering Section 11 ACA Application
The core question was whether the filing of a Section 7 IBC proceeding creates an embargo on the Court's ability to consider a Section 11 ACA application to appoint an arbitral tribunal. The Court noted that the arbitration agreement between the parties was undisputed, and the invocation of the arbitration agreement had occurred. The Court emphasized that the primary consideration for exercising jurisdiction under Section 11(6) ACA was present.

Issue 2: Maintainability of Section 11 Application
The respondent opposed the maintainability of the Section 11 application, arguing that it was an afterthought to dilute the prior IBC proceedings. The respondent contended that the applicant had admitted liability and issued a dishonored cheque, thus the Section 11 application was an attempt to evade IBC consequences. The Court, however, observed that the mere filing of Section 7 IBC proceedings does not preclude the Court from exercising jurisdiction under Section 11 ACA, as the Section 7 proceedings had not yet been admitted by the NCLT.

Issue 3: Impact of Supreme Court Decision in "Indus Biotech"
Both parties referred to the Supreme Court's decision in "Indus Biotech." The respondent argued that IBC proceedings should be given primacy until the NCLT passes an order under sub-section (5) of Section 7. The applicant countered that pre-admission IBC proceedings do not create an embargo on Section 11 ACA applications. The Court agreed with the applicant, noting that the Supreme Court had distinguished between pre-admission and post-admission stages of Section 7 IBC proceedings, with only post-admission proceedings gaining the status of proceedings in rem.

Issue 4: Necessity of Filing Section 8 ACA Application Before NCLT
The respondent contended that the applicant should have filed a Section 8 ACA application before the NCLT. The Court rejected this argument, stating that accepting it would lead to an anomalous situation where mere filing of Section 7 IBC proceedings would oust the remedy available under the ACA. The Court held that the right to enforce an arbitration agreement remains until the Section 7 IBC proceedings are admitted.

Conclusion:
The Court concluded that the mere filing of Section 7 IBC proceedings does not create an embargo on exercising jurisdiction under Section 11 ACA. The Court would not be precluded from appointing an arbitral tribunal as the NCLT had not yet admitted the Section 7 IBC proceedings. However, the Court noted that a formal order appointing an arbitral tribunal was unnecessary as the parties had settled their disputes, rendering arbitration unwarranted. The petition was accordingly disposed of.

 

 

 

 

Quick Updates:Latest Updates